Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment

Onkologie

Volumn 31, Issue 8-9, 2008, Pages 435-439

  Montemor, José Paulo ^a   Peria, Fernanda Maris ^a   Monti, Carlos Roberto ^b   Petrilli, Luis Salvador ^b   Colli, Benedicto Oscar ^a   Carlotti Jr , Carlos Gilberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b RADIUM Institute of Radiotherapy   (Brazil)

Author keywords

Chemoradiotherapy; Malignant glioma, overall survival; Paclitaxel; Toxicity

Indexed keywords

DEXAMETHASONE; PACLITAXEL; RANITIDINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BRAIN; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; NEUTROPENIA; RANDOMIZATION; SKIN TOXICITY; THROMBOCYTOPENIA; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 52249119197     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141517     Document Type: Article

References (30)

1. Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN: Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 2004;10:228-233.
2. Hentschel SJ, Sawaya R: Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 2003;10:109-114.
3. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002;359:1011-1018.
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352 987-996.
5. Kortmann RD, Jeremic B, Weller M, Plasswilm ML, Bamberg M: Chemoradiotherapy of malignant glioma in adults - clinical experiences. Strahlenther Onkol 2003;179:219-232.
6. Schiff PB, Fant J, Horwitz SB: Promotion of microtubule assembly in vitro by taxol. Nature 1979;277:665-667.
7. Parness J, Horwitz SB: Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981;91:479-487.
8. Manfredi JJ, Parmess J, Horwitz SB: Taxol binds to cellular microtubules. J Cell Biol 1982;94:688-696.
9. Geard CR, Jones JM, Schiff PB: Taxol and radiation. J Natl Cancer Inst Monogr 1993;15:89-94.
10. Cahan MA, Walter KA, Colvin OM, Brem H: Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 1994;33:441-444.
11. Helson L, Helson C, Malik S, Ainsworth S, Mangiardi J: A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anticancer Drugs 1993;4:487-490.
12. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G: Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 1997;75:1744-1752.
13. Silbergeld DL, Chicoine MR, Madsen CL: In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anticancer Drugs 1995;6:270-276.
14. Julka PK, Awasthy BS, Rath GK, Agarwal S, Varna T, Mahapatra AK, Singh R: A study of concurrent chemoradiotherapy with paclitaxel in glioblastoma multiforme. Australas Radiol 2000;44:84-87.
15. Fountzilas G, Karavelis A, Capizzello A, Kalogera-Fountzila A, Karkavelas G, Zamboglou N, Selviaridis P, Foroglou G, Tourkantonis A: Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme - a phase II study. J Neurooncol 1999;45:159-165.
16. Langer CJ, Ruffer J, Rhodes H, Paulus R, Murray M, Movsas B, Curran W: Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;51:113-119.
17. Glantz MJ, Choy H, Kearns CM, Cole BF, Mills P, Zuhowski EG, Saris S, Rhodes CH, Stopa E, Egorin MJ: Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. J Clin Oncol 1996;14:600-609.
18. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan AE: Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 2008;108:642-648.
19. Briasoulis E, Tzamakou E, Nicolaides C, Karavasilis V, Pavlidis N: Long-term weekly administration of paclitaxel in chemotherapy-naïve patients, phase I study: single versus cumulative dose limiting toxicity: Proc Am Soc Clin Oncol 1997;16:812.
20. WHO: Handbook for reporting results of cancer treatment. Geneva, World Health Organization, Offset Publication no 48;1979.
21. MacDonald DR, Cascino TL, Schald SC, Cairncross, JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
22. Hegedus B, Zách J, Czirók A, Lövey J, Vicsek T: Irradiation and Taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells. J Neurooncol 2004;67:147-157.
23. Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang SM: Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 1996;14:2316-2321.
24. Chamberlain MC, Kormanik P: Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. J Clin Oncol 13(1995) 2066-2071.
25. Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC Jr, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD: Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 1998;16:2188-2194.
26. Koziara JM, Lockman PR, Allen DD, Mumper RJ: Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004;99:259-269.
27. Ding L, Lee T, Wang CH: Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization. J Control Release 2005;102:395-413.
28. Altinoz MA, Bilir A, Del Maestro RF, Tuna S, Ozcan E, Gedikoglu G: Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro. Surg Neurol 2006;65:478-484.
29. Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T, Bernhardt G, Graeff C, Färber L, Gschaidmeier H, Buschauer A, Fricker G. Transport of paclitaxel (Taxol) across the bloodbrain barrier in vitro and in vivo. J Clin Invest 2002;110:1309-1318.
30. Li KW, Dang W, Tyler BM, Troiano G, Tihan T, Brem H, Walter KA: Polilactofate microspheres for paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 2003;9:3441-3447.